Capital Flow Monitor · Sponsors · CIK 2153574
Cloverleaf Bio, Inc.
101 COLLEGE STREET, #210, NEW HAVEN, CT, 06510 · 347-596-9754
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$29.6M
Sold
$14.8M
% sold
50.0%
Investors
12
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-09 | D ·current | 506(b) | $29.6M | $14.8M | 50.0% | 12 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Austin Draycott — Executive Officer / Director, New Haven, CT
- Cole Lewis — Executive Officer, New Haven, CT
- Dima Kuzmin — Director, New Haven, CT
- Christina Vorvis — Director, New Haven, CT
- Matthias Samwer — Director, New Haven, CT
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.